Chief Financial Officer update

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





24 March 2026
Chief Financial Officer update
AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic
pharmaceuticals company, today advises Chief Financial Officer-designate Simon
Bosley has decided not to take up the role for personal reasons.
Simon has, however, committed to remain with the company until the end of July,
while it recruits a new Chief Financial Officer to replace Malcolm Tubby, who is to retire
at the end of May 2026.
AFT Managing Director Dr Hartley Atkinson thanked Simon for his engagement and his
support during the transition period.
Released for and on behalf of AFT Pharmaceuticals Limited by Malcolm Tubby, Chief
Financial Officer.
For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

About AFT Pharmaceuticals
AFT is a growing New Zealand based multinational pharmaceutical company that
develops, markets, and distributes a broad portfolio of pharmaceutical products
across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over the counter (OTC), prescription, and
hospital. Our product portfolio comprises both proprietary and in-licensed products,
and includes patented, branded, and generic drugs. Our business model is to
develop and in-license products for in our markets of Australia, New Zealand,
Singapore, Malaysia, Hong Kong, USA, Canada, EU ex Ireland, and UK, and to out-
license our products to local licensees and distributors to over 125 countries around
the world. For more information about the company, visit our website
www.aftpharm.com.